+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field



Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field



Japanese Journal of Antibiotics 45(1): 48-73



Bacteriological, pharmacokinetic and clinical studies on cefdinir (CFDN, FK482), a new oral cephalosporin, 5% and 10% granules, were performed in the field of pediatrics. The results are summarized below. 1. Antibacterial activities Antibacterial activities of CFDN against Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, Branhamella catarrhalis, Escherichia coli and Klebsiella pneumoniae were studied in comparison with those of cefaclor (CCL), cefixime (CFIX) and amoxicillin (AMPC). MIC80's of CFDN against S. aureus, S. pneumoniae, S. pyogenes, H. influenzae, B. catarrhalis, K. pneumoniae and E. coli were 0.78, 0.20, less than or equal to 0.025, 0.39, 0.10, 0.20 and 0.10 micrograms/ml, respectively. These results show that CFDN has high antibacterial activities against these organisms. MIC80's of CFDN against Gram-positive bacteria were similar to those of AMPC, and was lower than those of CCL and CFIX. As for antibacterial activities against Gram-negative bacteria (GNB), the MIC80 of CFIX against H. influenzae was 0.05 micrograms/ml, which was slightly lower than that of CFDN. THe MIC80's of CFDN against other GNB were similar to those of CFIX. 2. Absorption and excretion Blood concentrations and urinary excretion rates of CFDN 5% and 10% granules and 100 mg capsule were determined. The data on CFDN 10% granules were similar to those on CFDN 5% granules. At a dose of 3 mg/kg, peak blood concentrations (Cmax's) of CFDN ranged from 0.20 to 2.12 micrograms/ml with 5% granules and from 0.50 to 1.15 micrograms/ml with 10% granules at 2 to 3 hours after dosing. At a dose of 6 mg/kg, peak concentrations were 0.66-2.06 micrograms/ml and 0.70-1.52 micrograms/ml with 5% granules and with 10% granules, respectively. At 8 hours after dosing, blood concentrations were 0.04-0.54 micrograms/ml at 3 mg/kg and 0.06-0.27 micrograms/ml at 6 mg/kg. Blood half-lives were 1.33-4.36 hours at 3 mg/kg and 1.14-3.27 hours at 6 mg/kg. AUC's were 1.7-11.0 micrograms.hr/ml with 3 mg/kg and 2.4-8.7 micrograms.hr/ml with 6 mg/kg. With administration of single 100 mg capsule, Cmax's, blood concentrations after 8 hours, T1/2's and AUC's were 0.79-1.88 micrograms/ml, 0.20 micrograms/ml, 1.54-2.72 hours, and 5.2 micrograms.hr/ml, respectively. Urinary recovery rates in the first 8 hours ranged from 6.85 to 39.2% with 3 mg/kg and 6.08-25.5% with 6 mg/kg.(ABSTRACT TRUNCATED AT 400 WORDS)

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039365453

Download citation: RISBibTeXText

PMID: 1495196


Related references

Pharmacokinetic, bacteriological and clinical studies on cefdinir fine granules in the field of pediatrics. Japanese Journal of Antibiotics 44(10): 1158-1167, 1991

Pharmacokinetic and clinical studies of cefdinir in the pediatric field. Pediatric Study Group of Cefdinir. Japanese Journal of Antibiotics 44(10): 1168-1191, 1991

Clinical studies on cefdinir granules in pediatric field. Japanese Journal of Antibiotics 43(8): 1450-1461, 1990

Pharmacokinetic, bacteriological and clinical evaluations of cefdinir 10% fine granules in pediatrics. Japanese Journal of Antibiotics 44(10): 1119-1133, 1991

Pharmacokinetic and clinical studies of cefdinir in pediatric field. Japanese Journal of Antibiotics 43(10): 1783-1788, 1990

Laboratory and clinical studies on cefdinir (10% fine granules) in pediatric field. Japanese Journal of Antibiotics 44(10): 1134-1141, 1991

Laboratory and clinical studies of cefdinir 5% and 10% fine granules in pediatric field. Japanese Journal of Antibiotics 44(10): 1142-1157, 1991

Pharmacokinetic and clinical studies on cefdinir fine granules in children. Japanese Journal of Antibiotics 43(10): 1789-1795, 1990

Bacteriological pharmacokinetic and clinical studies on aztreonam in the pediatric field. Japanese Journal of Antibiotics 38(11): 3195-3216, 1985

Pharmacokinetic, bacteriological and clinical studies in the pediatric field on clarithromycin. Japanese Journal of Antibiotics 42(2): 281-303, 1989

Bacteriological, pharmacokinetic and clinical studies on biapenem (L-627) in the pediatric field. Japanese Journal of Antibiotics 47(12): 1728-1752, 1994

Pharmacokinetic, bacteriological and clinical studies of SY5555 in the pediatric field. Japanese Journal of Antibiotics 48(2): 238-260, 1995

Pharmacokinetic, bacteriological and clinical studies on cefozopran in the pediatric field. Japanese Journal of Antibiotics 47(11): 1589-1611, 1994

Pharmacokinetic, bacteriological and clinical studies in the pediatric field on norfloxacin. Japanese Journal of Antibiotics 43(5): 799-807, 1990

Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field. Japanese Journal of Antibiotics 45(12): 1700-1735, 1992